drugset / Trial / NCT01556100
Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression
NaSingle-groupOpen-labelDiagnostic
Summary
A total 40 PD subjects will be included in this study. PD subjects between 20 and 80 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, and blood test.
Timeline
- Start
- 2011-11
- Primary completion
- 2015-05
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-DTBZ AV-133 | Diagnostic / imaging agent | — | — |